Indeed, the echinoderm microtubule-associated protein-like 4 (EML4)-ALK gene fusion has been detected in a small subset of non-small cell lung cancers7, and the efficacy of using ALK inhibitors to treat lung cancer patients who harbor the EML4-ALK fusion has been evident in clinical trials8, 9. This evidence concerns the gene ALK and lung carcinoma.